trending Market Intelligence /marketintelligence/en/news-insights/trending/W94wavFByTDhl2OZ0wZr2w2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Catalent unit closes deal on leasing gene therapy facilities from Novavax

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Catalent unit closes deal on leasing gene therapy facilities from Novavax

Catalent Inc.'s Paragon Gene Therapy unit assumed leases for two Novavax Inc. facilities in Gaithersburg, Md., and purchased manufacturing equipment and related assets for about $18 million.

Paragon Gene Therapy, which specializes in gene therapies, vaccines and antibody-drug conjugates, also hired 100 Novavax employees, as part of the transaction agreed in late June. The deal is now closed.

The deal provides Paragon with resources to accelerate the growth of its gene therapy development and contract manufacturing businesses, according to a news release.

Novavax said projected cost savings from the personnel and lease transfers, along with proceeds from the asset sale will enable it to conduct a phase 3 clinical trial for its vaccine NanoFlu.

The trial is scheduled to begin in the third quarter.

Additionally, Novavax entered into a services arrangement to receive certain development and manufacturing services from the Somerset, N.J.-based Catalent's Paragon.